(1)On 30 June 2017, VEOLIA WATER SOLUTIONS & TECHNOLOGIES SUPPORT (the ‘applicant’) submitted an application to the European Chemicals Agency (‘the Agency’) in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013note for Union authorisation of the same biocidal product family, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013. That biocidal product family was named ‘VEOLIA WATER TECHNOLOGIES CMIT/MIT biocidal product family’, of product-types 6, 11, 12 and 13, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-MG032941-44 in the Register for Biocidal Products. The application also indicated the case number of the related reference product family ‘LANXESS CMIT/MIT biocidal product family’, later authorised by Commission Implementing Regulation (EU) 2024/2750note, with authorisation number EU-0031652-0000.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.